检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:廉建伟[1] 李伟[1] 马爱玲[1] 毕开顺[1] 陈晓辉[1]
机构地区:[1]沈阳药科大学药学院药物分析教研室,沈阳110016
出 处:《中国临床药学杂志》2008年第4期238-242,共5页Chinese Journal of Clinical Pharmacy
摘 要:目的建立测定人血浆样品中硝苯地平浓度的LC-MS方法,并应用于硝苯地平缓释片的人体生物等效性研究。方法20名男性健康受试者交叉口服单剂量和多剂量受试制剂或参比制剂,以地西泮为内标,血浆样品经液-液萃取后,测定血药浓度,计算药动学参数和相对生物利用度,评价两制剂的生物等效性。结果单剂量口服受试制剂与参比制剂的主要药动学参数:t_(max)分别为(2.2±0.7)和(2.3±0.8)h;ρ_(max)分别为(68.3±23.2)和(71.1±18.6)μg·L^(-1);t_(1/2)分别为(6.0±2.1)和(6.2±3.4)h;受试制剂的相对生物利用度为(97.5±15.6)%。多剂量口服受试制剂与参比制剂的主要药动学参数(稳态时):t_(max)分别为(2.0±0.8)和(2.2±0.9)h;ρ_(max)分别为(63.1±26.8)和(63.5±2,4.7)μg·L^(-1);t_(1/2)分别为(7.1±2.6)和(7.2±2.6)h;受试制剂的相对生物利用度为(97.1±30.5)%。结论本方法准确可靠,操作快速、简便。受试制剂与参比制剂生物等效。AIM To develop a LC-MS method for determining the nifedipine in human plasma. The pharmaeokineties and bioequivalenee of nifedipine sustained-release tablets were studied. METHODS The human plasma samples were obtained at certain time points after a single or multiple oral dose of the test or reference formulations. Plasma samples were processed by liquid-liquid extraction using diazepam as the internal standard. The phannaeokinetie parameters were calculated and the bioequivalenee of nifedipine sustained-release tablets were evaluated. RESULTS The main pharmaeokinetie parameters of nifedipine test and reference formulations after a single oral administration were as follows: tmax(2.2±0.7) and (2.3 ±0.8)h;ρmax(68.3 ±23.2)and(71.1 ± 18.6)μg·L^-16.0± 2.1) and (6.2±3.4) h.The relative bioavailability of nifedipine sustained-release tablets was (97.5 ±15.6) %. The main phannaeokinetie parameters after a multiple oral administration were as follows: tmax(2.0 ±0.8) and (2.2 ±0.9) h;ρmax(63.1 ± 26.8) and (63.5± 24.7)μg·L^-1 ; t 1/2 (7.1 ± 2.6) and (7.2 ±2.6) h. The relative bioavailability of nifedipine sustained-release tablets was (97.1 ± 30.5)%. CONCLUSION Tne developed LC-MS method is reliable, rapid and simple. Tne statistical analysis results show that the two formulations are bioequivalent.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3